SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Pharmos(PARS) -- Ignore unavailable to you. Want to Upgrade?

To: NeuroInvestment who wrote (996)7/14/1998 5:51:00 PM
From: yosi s  Respond to of 1491
 
I agree with the neuroinvestor analysis as to time frame. also a lot depends on phase 2 response the greater response the lesser the cohort,the faster the recruitment of patients. 3-4 or more years does not make sense, may be some one can call in pars and get clarfication. news reporters easily misquote.



To: NeuroInvestment who wrote (996)7/14/1998 5:56:00 PM
From: Don Walster  Read Replies (1) | Respond to of 1491
 
Thank you for your informative response. Would you assume that not much will happen to Pharmos stock until the end of 2,000, or, in your opinion, is there some possibility that interim information may be beneficial to the value of the stock?
Kinest regards,
Don Walster


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News